Tag: vaccine
Aluminum (Al)-containing vaccines are common in sheep management and they have been associated with the Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA syndrome). The aim of this study was to investigate cognitive and behavioral changes in sheep subjected to a protocol of repetitive inoculation with Al-containing products.
Since the peripheral cytokines, produced after the injection of the vaccines, are able to reach the central nervous system, we hypothesize that these cytokines can have effects on the microglia (macrophages of the central nervous system), and that these effects can be facilitated by repeated vaccinations to infants during the first year of life.
Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature
A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of aluminium adjuvants used in vaccines versus placebo or no intervention, taking into consideration the type of the vaccine, and the type, size, and concentration of the aluminium adjuvant.
This chapter reviews liability for vaccine injuries historically; the rationale, development, and implementation of the National Vaccine Injury Compensation Program (VICP); and the program’s current status. The first part of the chapter dis-cusses the development of the law in the United States until 1986, the year of the passage of the National Childhood Vaccine Injury Act of 1986 (NCVIA). Later sections discuss the administration of the VICP, reported decisions relating to liability for the production and administration of vaccines after 1986, and current developments in the area of vaccine injury liability and compensation.
Pancreatitis after human papillomavirus vaccination: a matter of molecular mimicry
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil